Inventor · disambiguated record
Robert E. Reiter
Also filed as: REITER ROBERT E
38 granted patents·13 pending applications·869 citations·filing 1997–2023
98Inventor score
Top patents by PatentIndex Score
51 records- 0197US6979730B2Nucleic acids encoding prostate stem cell antigenUNIV CALIFORNIA·Filed 2003·Granted Dec 27, 2005·71 cites·4 claims
- 0296US6828471B2Mice models of human prostate cancerUNIV CALIFORNIA·Filed 2002·Granted Dec 7, 2004·44 cites·6 claims
- 0395US8404817B2Humanized anti-prostate stem cell antigen monoclonal antibodySHERMAN MARK A·Filed 2011·Granted Mar 26, 2013·43 cites·4 claims
- 0494US8940871B2Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targetingWU ANNA M·Filed 2007·Granted Jan 27, 2015·39 cites·10 claims
- 0594US6825326B2PSCA: prostate stem cell antigen and uses thereofUNIV CALIFORNIA·Filed 2001·Granted Nov 30, 2004·33 cites·23 claims
- 0694US6790939B2Anti-PSCA antibodiesUNIV CALIFORNIA·Filed 2001·Granted Sep 14, 2004·33 cites·10 claims
- 0794US6756036B2Methods for treating cancer using PSCA antibodies and fragments thereofUNIV CALIFORNIA·Filed 2001·Granted Jun 29, 2004·32 cites·28 claims
- 0894US6541212B2Methods for detecting prostate stem cell antigen proteinUNIV CALIFORNIA·Filed 2000·Granted Apr 1, 2003·34 cites·13 claims
- 0993US6881822B2PSCA: prostate stem cell antigen and uses thereofUNIV CALIFORNIA·Filed 2001·Granted Apr 19, 2005·30 cites·16 claims
- 1090US7485296B2PSCA: prostate stem cell antigen and uses thereof in pancreatic cancerUNIV CALIFORNIA·Filed 2004·Granted Feb 3, 2009·17 cites·12 claims
- 1190US7407656B2PSCA: prostate stem cell antigen and uses thereofUNIV CALIFORNIA·Filed 2004·Granted Aug 5, 2008·18 cites·24 claims
- 1290US6258939B1PSCA antibodies and hybridomas producing themUNIV CALIFORNIA·Filed 1998·Granted Jul 10, 2001·94 cites·3 claims
- 1388US8940298B2High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detectionWU ANNA M·Filed 2008·Granted Jan 27, 2015·13 cites·33 claims
- 1488US8088908B2Humanized anti-prostate stem cell antigen monoclonal antibodySHERMAN MARK A·Filed 2006·Granted Jan 3, 2012·10 cites·5 claims
- 1588US7527786B2Methods for inhibiting the growth of cancer cells expressing PSCAUNIV CALIFORNIA·Filed 2002·Granted May 5, 2009·15 cites·22 claims
- 1687US7053263B2Mouse models of human prostate cancer progressionUNIV CALIFORNIA·Filed 2001·Granted May 30, 2006·18 cites·7 claims
- 1786US6960443B2Methods of detecting prostate stem cell antigen in cancerUNIV CALIFORNIA·Filed 2002·Granted Nov 1, 2005·28 cites·11 claims
- 1886US6093800AE25a protein, methods for production and use thereofUNIV CALIFORNIA·Filed 1997·Granted Jul 25, 2000·42 cites·1 claims
- 1985US7030232B1E25A protein, methods for producing and use thereofUNIV CALIFORNIA·Filed 1999·Granted Apr 18, 2006·39 cites·15 claims
- 2080US7417113B2PSCA: prostate stem cell antigen and uses thereofUNIV CALIFORNIA·Filed 2003·Granted Aug 26, 2008·6 cites·16 claims
- 2180US7122714B2Mouse models of human prostate cancerUNIV CALIFORNIA·Filed 2002·Granted Oct 17, 2006·5 cites·6 claims
- 2279US6365797B1Mice models of human prostate cancer progressionUNIV CALIFORNIA·Filed 2000·Granted Apr 2, 2002·18 cites·17 claims
- 2379US6261791B1Method for diagnosing cancer using specific PSCA antibodiesUNIV CALIFORNIA·Filed 1999·Granted Jul 17, 2001·45 cites·5 claims
- 2478US8759006B2PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasiaREITER ROBERT E·Filed 2008·Granted Jun 24, 2014·1 cites·5 claims
- 2578US7462691B2Mouse prostate stem cell antigen and uses thereofUNIV CALIFORNIA·Filed 2004·Granted Dec 9, 2008·4 cites·1 claims
- 2678US6949690B2Methods of assessing the effect of a gene of interest on human prostate cancer progressionUNIV CALIFORNIA·Filed 2002·Granted Sep 27, 2005·4 cites·6 claims
- 2777US8703920B2Fully human antibodies against N-cadherinREITER ROBERT E·Filed 2009·Granted Apr 22, 2014·2 cites·3 claims
- 2877US8663635B2N-cadherin: target for cancer diagnosis and therapyREITER ROBERT E·Filed 2008·Granted Mar 4, 2014·2 cites·10 claims
- 2977US6261789B1Methods for detecting the presence of a PSCA protein using PSCA antibodiesUNIV CALIFORNIA·Filed 1999·Granted Jul 17, 2001·44 cites·6 claims
- 3077US6107540AMice models of human prostate cancer progressionUNIV CALIFORNIA·Filed 1997·Granted Aug 22, 2000·47 cites·17 claims
- 3172US6267960B1PSCA: prostate stem cell antigenUNIV CALIFORNIA·Filed 1998·Granted Jul 31, 2001·30 cites·5 claims
- 3270US2024026025A1Humanized anti-n-cadherin antibodies and uses thereofUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 3369US2014364591A1Psca: prostate stem cell antigen and uses thereofUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 3466US6956145B2Mice models of human prostate cancer progressionUNIV CALIFORNIA·Filed 2002·Granted Oct 18, 2005·4 cites·7 claims
- 3566US6815574B2Methods of simulating human prostate cancer progressionUNIV CALIFORNIA·Filed 2002·Granted Nov 9, 2004·4 cites·14 claims
- 3666US2016347855A1Psca: prostate stem cell antigen and uses thereofUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 3763US8524460B2PSCA: prostate stem cell antigen and uses thereofREITER ROBERT E·Filed 2011·Granted Sep 3, 2013·0 cites·17 claims
- 3861US7595431B2Mouse models of human prostate cancerUNIV CALIFORNIA·Filed 2006·Granted Sep 29, 2009·0 cites·11 claims
- 3959US9527919B2High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detectionUNIV CALIFORNIA·Filed 2014·Granted Dec 27, 2016·0 cites·33 claims
- 4058US9388247B2Antibodies against cancer target block tumor growth, angiogenesis and metastatisREITER ROBERT E·Filed 2009·Granted Jul 12, 2016·0 cites·13 claims
- 4157US9470689B2N-cadherin: target for cancer diagnosis and therapyUNIV CALIFORNIA·Filed 2013·Granted Oct 18, 2016·0 cites·11 claims
- 4257US2020165351A1Humanized anti-n-cadherin antibodies and uses thereofUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 4353US2023181772A1Engineered anti-prostate stem cell antigen fusion proteins and uses thereofHOPE CITY·Filed 2021·Application pending·0 cites
- 4452US2014017240A1Fully Human Antibodies Against N-CadherinUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 4550US2015175706A1Novel Antibodies Against Cancer Target Block Tumor Growth, Angiogenesis and MetastatisUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 4647US2009130108A1N-Cadherin and Ly6 E: Targets for Cancer Diagnosis and TherapyUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 4747US2008318254A9PSCA antibodies and hybridomas producing themUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 4844US2010278821A1N-cadherin: target for cancer diagnosis and therapyUNIV CALIFORNIA·Filed 2010·Application pending·0 cites
- 4943US2013274128A1Gene expression in n-cadherin overexpressing prostate cancers and their controlsREITER ROBERT E·Filed 2011·Application pending·0 cites
- 5042US2013137584A1Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignanciesREITER ROBERT E·Filed 2011·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert E. Reiter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →